Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079222 · ClinicalTrials.gov registry record · NA
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
NCT00079222: Completed NA study, sponsored by Jonsson Comprehensive Cancer Center.
NCT00079222 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00079222, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation. PURPOSE: This randomized clinical trial is studying voriconazole to see how well it works compared to itraconazole in preventing fungal infections in patients who are undergoing allogeneic hematopoietic stem cell transplantation.
Interventions
- DRUG itraconazole
- DRUG voriconazole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-11 |
| Phase | NA |
What the finished NCT00079222 record still lists
NCT00079222 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which itraconazole is the first listed.
NCT00079222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00079222 about?
NCT00079222 is a clinical study titled "Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation". RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation. PURPOSE: This randomized clinical trial is studying voriconazole to see how well it works compared to itraconazole in ...
What is the current status of trial NCT00079222?
This trial is currently completed. It is a NA study. The study started on 2003-11.
What interventions are being tested in trial NCT00079222?
The interventions under investigation include: itraconazole (DRUG), voriconazole (DRUG).
Who is sponsoring clinical trial NCT00079222?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia